Diese Veranstaltung hat bereits stattgefunden.
Folgende kommende Veranstaltungen könnten Sie interessieren:
27.01.2021 Allgemeine Sprechstunde
27.01.2021 Online peer discussion - Binocular vision, COVID-19
28.01.2021 Fortbildung Augenklinik
28.01.2021 Berner Fortbildung für Augenärzte: Netzhautfortbildung
29.01.2021 70th Annual Symposium of the NOAO


online, USA


The Johns Hopkins Wilmer Eye Institute CME Activity

23.01.2021, 13:30 - 23.01.2021
The Johns Hopkins Wilmer Eye Institute
Over the past several years, there is a growing body of medical evidence demonstrating a clear biologic rationale for targeting vascular endothelial growth factors in the treatment of the neovascular form of agerelated macular degeneration, diabetic retinopathy, and related diseases.


Max. Teilnehmer: unbegrenzt
Gebühren ab: k.A.

Ärzte/-innen in Weiterbildung

Max. Teilnehmer: unbegrenzt
Gebühren ab: k.A.


Max. Teilnehmer: unbegrenzt
Gebühren ab: k.A.

Diese Veranstaltung findet einmalig statt und bietet Fortbildungsmöglichkeiten für Fachärzte, Ärzte/-innen in Weiterbildung und Studenten/-innen.
Veranstaltungsnummer: 34778
Gebühren ab:  
verfügbare Plätze: unbegrenzt
Sprache: Englisch
Vom Veranstalter gemeldetes Programm:

Furthermore, there are new imaging and therapeutic approaches to vitreomacular interface abnormalities, intraocular tumors, posterior uveitis, hereditary retinal degenerations, as well as surgical diseases of the retina. These areas of investigation are relatively new, and most ophthalmologists are not aware of the myriad of new clinical trials relevant to these diseases. Thus, these subjects are areas of great interest both to ophthalmologists who treat these diseases and to those who refer these cases for further management. Presentations were chosen to emphasize new information and consensus on the use of these biologic agents to treat the neovascular and non-neovascular forms of age-related macular degeneration, vitreomacular interface abnormalities, diabetic retinopathy, intraocular tumors, and posterior uveitis. In addition, cases were chosen highlighting new information being reported by randomized clinical trials in these disease areas.

  • Recognize the role of anti-angiogenic treatments for eyes with choroidal neovascularization from age-related macular degeneration or diabetic retinopathy, including proliferative diabetic retinopathy and diabetic macular edema.
  • Evaluate recent clinical studies evaluating treatments for hereditary retinal degenerations.
  • Recognize the role of imaging in the management of vitreomacular interface abnormalities.
  • Review the current and emerging therapeutic approaches for surgical retinal diseases.
  • Summarize the evidence of surgical and medical treatments for intraocular tumors.
  • Detect which patients are appropriate for biologic treatments of posterior uveitis.
This events takes place virtualy

online, USA
The Johns Hopkins Wilmer Eye Institute

The Johns Hopkins Wilmer Eye Institute
Center of Excellence for Ophthalmic Surgical Education and Training
600 North Wolfe Street
US - MD 21287 Baltimore


Registration required. Please contact the organizer for further information.